CTNM (STOCKS)
Contineum Therapeutics, Inc. Class A Common Stock
$15.300000
+0.320000 (+2.14%)
Prev close: $14.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Carmine N. Stengone
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $575.60M
- Employees
- 41
- P/E (TTM)
- -8.62
- P/B (TTM)
- 2.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.40 | $-0.46 | +0.0607 | +13.18% |
|
Mar 2026 (Q1)
|
$-0.39 | $-0.54 | +0.1521 | +28.06% |
|
Dec 2025 (Q4)
|
$-0.49 | $-0.41 | -0.0762 | -18.41% |
|
Sep 2025 (Q3)
|
$-0.45 | $-0.49 | +0.0434 | +8.80% |